{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:49:37Z","timestamp":1787993377732,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008645","name":"Terumo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008645","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Joint Federal Committee","award":["01VSF16008"],"award-info":[{"award-number":["01VSF16008"]}]},{"DOI":"10.13039\/501100008384","name":"Stifterverband","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016021","name":"CORONA Foundation","doi-asserted-by":"crossref","award":["S199\/10061\/2015"],"award-info":[{"award-number":["S199\/10061\/2015"]}],"id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Joint Federal Committee","award":["01VSF18035"],"award-info":[{"award-number":["01VSF18035"]}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007534","name":"Braun Melsungen AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007534","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of the University Heart and Vascular Centre Hamburg"},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["U01FD005478"],"award-info":[{"award-number":["U01FD005478"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejvs.2020.06.033","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T12:00:54Z","timestamp":1597406454000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Long Term Outcomes After Revascularisations Below the Knee with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis"],"prefix":"10.1016","volume":"60","author":[{"given":"Franziska","family":"Heidemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-8410","authenticated-orcid":false,"given":"Frederik","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Kuchenbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Kreutzburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Art","family":"Sedrakyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"L'Hoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike S.","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian-Alexander","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2020.06.033_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2020.06.033_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib3","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.06.033_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003468","article-title":"Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis","volume":"9","author":"Mustapha","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.06.033_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11596-014-1285-1","article-title":"Different responses of cell cycle between rat vascular smooth muscle cells and vascular endothelial cells to paclitaxel","volume":"34","author":"Jing","year":"2014","journal-title":"J\u00a0Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.ejvs.2020.06.033_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.06.033_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.06.033_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jvs.2016.10.089","article-title":"Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty","volume":"65","author":"Candy","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib10","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jcin.2015.07.011","volume":"8","author":"Zeller","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.06.033_bib11","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.033_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2020.06.033_bib13","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2020.06.033_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.033_bib15","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","author":"Freisinger","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.06.033_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11936-019-0765-9","article-title":"Paclitaxel-based devices for the treatment of PAD: balancing clinical efficacy with possible risk","volume":"21","author":"Krawisz","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.ejvs.2020.06.033_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","article-title":"Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Katsanos","year":"2020","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2020.06.033_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12874-017-0407-4","article-title":"The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data","volume":"17","author":"Czwikla","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2020.06.033_bib20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00103-008-0646-y","article-title":"Validation of secondary data. Strengths and limitations","volume":"51","author":"Hoffmann","year":"2008","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.ejvs.2020.06.033_bib21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12889-015-1943-7","article-title":"Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study","volume":"15","author":"Ohlmeier","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejvs.2020.06.033_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028223","article-title":"Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry","volume":"9","author":"Langner","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2020.06.033_bib23","article-title":"A\u00a0retrospective cohort study on the provision and outcomes of pharmacological therapy after revascularization for peripheral arterial occlusive disease: a study protocol","volume":"2","author":"Peters","year":"2020","journal-title":"BMJ Surg Interv Health Tec"},{"key":"10.1016\/j.ejvs.2020.06.033_bib24","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2020.06.033_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2020.06.033_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A\u00a0modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2020.06.033_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.zefq.2016.07.010","article-title":"[The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement]","volume":"115\u2013116","author":"Benchimol","year":"2016","journal-title":"Z\u00a0Evid Fortbild Qual Gesundhwes"},{"key":"10.1016\/j.ejvs.2020.06.033_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2020.06.033_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejvs.2017.01.002","article-title":"An international vascular registry infrastructure for medical device evaluation and surveillance","volume":"53","author":"Sedrakyan","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1024\/0301-1526\/a000778","article-title":"Outstanding effectiveness of paclitaxel-based technologies for the treatment of femoropopliteal artery occlusive disease on the potential expense of increased late all-cause mortality? No reason to panic","volume":"48","author":"Zeller","year":"2019","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2020.06.033_bib31","first-page":"72","article-title":"Real-world data collection regarding paclitaxel treatment","volume":"18","author":"Krawisz","year":"2019","journal-title":"Endovasc Today"},{"key":"10.1016\/j.ejvs.2020.06.033_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Long term survival after femoropopliteal artery revascularizations with paclitaxel-coated devices \u2013 a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.06.033_bib34","first-page":"205","article-title":"Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the Lutonix BTK trial","volume":"31","author":"Mustapha","year":"2019","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.033_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jcis.JCIS_34_17","article-title":"One year primary patency of infrapopliteal angioplasty using drug- eluting balloons: single center experience at king Hussein medical center","volume":"7","author":"Haddad","year":"2017","journal-title":"J\u00a0Clin Imaging Sci"},{"key":"10.1016\/j.ejvs.2020.06.033_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijsu.2016.09.014","article-title":"Drug-eluting balloon versus standard percutaneous transluminal angioplasty in infrapopliteal arterial disease: a meta-analysis of randomized trials","volume":"35","author":"Wu","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011319.pub2","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","author":"Kayssi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2020.06.033_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1358863X19871100","article-title":"Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system","volume":"25","author":"Reynolds","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2020.06.033_bib39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2020.06.033_bib40","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jvs.2013.12.013","article-title":"Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery","volume":"59","author":"De Martino","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejvs.2019.06.017","volume":"58","author":"Venermo","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.033_bib42","article-title":"Long term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia","volume":"6","author":"Spreen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2020.06.033_bib43","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2147\/CIA.S137570","article-title":"Mortality after major amputation in elderly patients with critical limb ischemia","volume":"12","author":"Klaphake","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ejvs.2020.06.033_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00270-013-0578-2","article-title":"Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials","volume":"36","author":"Katsanos","year":"2013","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858842030575X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858842030575X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:53:51Z","timestamp":1761047631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107858842030575X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S107858842030575X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.06.033","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long Term Outcomes After Revascularisations Below the Knee with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}